Department of Cardiology, National Heart Centre Singapore, Singapore.
Duke-NUS Medical School, Singapore.
Singapore Med J. 2021 Jun;62(6):300-304. doi: 10.11622/smedj.2020025. Epub 2020 Mar 17.
There is limited literature on clinical outcomes following percutaneous coronary intervention (PCI) in Asian dialysis patients. We evaluated the angiographic characteristics and clinical outcomes of dialysis patients treated with PCI in an Asian society.
A retrospective analysis was performed of 274 dialysis patients who underwent PCI in a tertiary care institution from January 2007 to December 2012. Data on clinical and angiographic characteristics was collected. The primary endpoint was major adverse cardiac events (MACE), defined as a composite of cardiac death, acute myocardial infarction (AMI) and stroke at two years.
274 patients (65.0% male, median age 62.0 years) with 336 lesions (81.8% Type B2) were treated. 431 stents (35.0% drug-eluting stents) with a mean diameter of 2.96 mm and mean length of 21.30 mm were implanted. The MACE rate was 55.8% (n = 153) at two years, from death (36.5%) and AMI (35.0%). In multivariable analysis, age and diabetes mellitus were significant predictors of both mortality (odds ratio [OR] 1.09, 95% confidence interval [CI] 1.05-1.12, p < 0.001; OR 2.65, 95% CI 1.46-4.82, p = 0.001, respectively) and MACE (OR 1.06, 95% CI 1.03-1.08, p < 0.001; OR 1.84, 95% CI 1.07-3.15, p = 0.027, respectively). Left ventricular ejection fraction (LVEF) (OR 0.97, 95% CI 0.95-0.99, p = 0.006) was a significant predictor of mortality but not MACE.
Asian dialysis patients who underwent PCI had a two-year MACE rate of 55.8% due to death and AMI. Age, LVEF and diabetes mellitus were significant predictors of mortality at two years.
亚洲透析患者经皮冠状动脉介入治疗(PCI)的临床结果相关文献有限。我们评估了亚洲社会接受 PCI 治疗的透析患者的血管造影特征和临床结果。
对 2007 年 1 月至 2012 年 12 月在一家三级医疗机构接受 PCI 的 274 例透析患者进行回顾性分析。收集了临床和血管造影特征的数据。主要终点是主要不良心脏事件(MACE),定义为两年时的心脏死亡、急性心肌梗死(AMI)和中风的复合终点。
274 例患者(65.0%为男性,中位年龄 62.0 岁)共 336 处病变(81.8%为 B2 型)接受治疗。植入了 431 个支架(35.0%为药物洗脱支架),直径为 2.96mm,长度为 21.30mm。两年时的 MACE 发生率为 55.8%(n=153),死亡(36.5%)和 AMI(35.0%)。多变量分析显示,年龄和糖尿病是死亡率(优势比[OR]1.09,95%置信区间[CI]1.05-1.12,p<0.001;OR 2.65,95%CI 1.46-4.82,p=0.001)和 MACE(OR 1.06,95%CI 1.03-1.08,p<0.001;OR 1.84,95%CI 1.07-3.15,p=0.027)的显著预测因素。左心室射血分数(LVEF)(OR 0.97,95%CI 0.95-0.99,p=0.006)是死亡率的显著预测因素,但不是 MACE。
亚洲透析患者 PCI 术后两年的 MACE 发生率为 55.8%,原因是死亡和 AMI。年龄、LVEF 和糖尿病是两年时死亡的显著预测因素。